Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 PCR
1.4.3 DNA Sequencing
1.4.4 NGS
1.5 Market by Application
1.5.1 Global Molecular Diagnosis and Therapy Market Share by Application (2019-2025)
1.5.2 Diagnostic Laboratories
1.5.3 Research & Academic Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Molecular Diagnosis and Therapy Market Size
2.2 Molecular Diagnosis and Therapy Growth Trends by Regions
2.2.1 Molecular Diagnosis and Therapy Market Size by Regions (2019-2025)
2.2.2 Molecular Diagnosis and Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Molecular Diagnosis and Therapy Market Size by by Players
3.1.1 Global Molecular Diagnosis and Therapy Revenue by by Players (2014-2019)
3.1.2 Global Molecular Diagnosis and Therapy Revenue Market Share by by Players (2014-2019)
3.1.3 Global Molecular Diagnosis and Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Molecular Diagnosis and Therapy Key Players Head office and Area Served
3.3 Key Players Molecular Diagnosis and Therapy Product/Solution/Service
3.4 Date of Enter into Molecular Diagnosis and Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Molecular Diagnosis and Therapy Market Size by Type (2014-2019)
4.2 Global Molecular Diagnosis and Therapy Market Size by Application (2014-2019)

5 North America
5.1 North America Molecular Diagnosis and Therapy Market Size (2014-2019)
5.2 Molecular Diagnosis and Therapy Key Players in North America
5.3 North America Molecular Diagnosis and Therapy Market Size by Type
5.4 North America Molecular Diagnosis and Therapy Market Size by Application

6 Europe
6.1 Europe Molecular Diagnosis and Therapy Market Size (2014-2019)
6.2 Molecular Diagnosis and Therapy Key Players in Europe
6.3 Europe Molecular Diagnosis and Therapy Market Size by Type
6.4 Europe Molecular Diagnosis and Therapy Market Size by Application

7 China
7.1 China Molecular Diagnosis and Therapy Market Size (2014-2019)
7.2 Molecular Diagnosis and Therapy Key Players in China
7.3 China Molecular Diagnosis and Therapy Market Size by Type
7.4 China Molecular Diagnosis and Therapy Market Size by Application

8 Japan
8.1 Japan Molecular Diagnosis and Therapy Market Size (2014-2019)
8.2 Molecular Diagnosis and Therapy Key Players in Japan
8.3 Japan Molecular Diagnosis and Therapy Market Size by Type
8.4 Japan Molecular Diagnosis and Therapy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Molecular Diagnosis and Therapy Market Size (2014-2019)
9.2 Molecular Diagnosis and Therapy Key Players in Southeast Asia
9.3 Southeast Asia Molecular Diagnosis and Therapy Market Size by Type
9.4 Southeast Asia Molecular Diagnosis and Therapy Market Size by Application

10 India
10.1 India Molecular Diagnosis and Therapy Market Size (2014-2019)
10.2 Molecular Diagnosis and Therapy Key Players in India
10.3 India Molecular Diagnosis and Therapy Market Size by Type
10.4 India Molecular Diagnosis and Therapy Market Size by Application

11 Central & South America
11.1 Central & South America Molecular Diagnosis and Therapy Market Size (2014-2019)
11.2 Molecular Diagnosis and Therapy Key Players in Central & South America
11.3 Central & South America Molecular Diagnosis and Therapy Market Size by Type
11.4 Central & South America Molecular Diagnosis and Therapy Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Molecular Diagnosis and Therapy Introduction
12.1.4 Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2014-2019))
12.1.5 Abbott Laboratories Recent Development
12.2 Agilent Technologies
12.2.1 Agilent Technologies Company Details
12.2.2 Company Description and Business Overview
12.2.3 Molecular Diagnosis and Therapy Introduction
12.2.4 Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.2.5 Agilent Technologies Recent Development
12.3 Becton, Dickinson and Company
12.3.1 Becton, Dickinson and Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Molecular Diagnosis and Therapy Introduction
12.3.4 Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.3.5 Becton, Dickinson and Company Recent Development
12.4 Biomérieux Sa
12.4.1 Biomérieux Sa Company Details
12.4.2 Company Description and Business Overview
12.4.3 Molecular Diagnosis and Therapy Introduction
12.4.4 Biomérieux Sa Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.4.5 Biomérieux Sa Recent Development
12.5 Danaher Corporation
12.5.1 Danaher Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Molecular Diagnosis and Therapy Introduction
12.5.4 Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.5.5 Danaher Corporation Recent Development
12.6 Diasorin
12.6.1 Diasorin Company Details
12.6.2 Company Description and Business Overview
12.6.3 Molecular Diagnosis and Therapy Introduction
12.6.4 Diasorin Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.6.5 Diasorin Recent Development
12.7 Grifols
12.7.1 Grifols Company Details
12.7.2 Company Description and Business Overview
12.7.3 Molecular Diagnosis and Therapy Introduction
12.7.4 Grifols Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.7.5 Grifols Recent Development
12.8 Hologic
12.8.1 Hologic Company Details
12.8.2 Company Description and Business Overview
12.8.3 Molecular Diagnosis and Therapy Introduction
12.8.4 Hologic Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.8.5 Hologic Recent Development
12.9 Illumina
12.9.1 Illumina Company Details
12.9.2 Company Description and Business Overview
12.9.3 Molecular Diagnosis and Therapy Introduction
12.9.4 Illumina Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.9.5 Illumina Recent Development
12.10 Qiagen
12.10.1 Qiagen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Molecular Diagnosis and Therapy Introduction
12.10.4 Qiagen Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.10.5 Qiagen Recent Development
12.11 Roche Diagnostics
12.12 Siemens AG
12.13 Thermo Fisher Scientific

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Abbott Laboratories、Agilent Technologies、Becton, Dickinson and Company、Biomérieux Sa、Danaher Corporation、Diasorin、Grifols、Hologic、Illumina、Qiagen、Roche Diagnostics、Siemens AG、Thermo Fisher Scientific

【免責事項】
https://www.globalresearch.jp/disclaimer